Category Archives: Newsletter

no menu

California Life Sciences Institute Names 2017 Winner of Amgen Bay Area BioGENEius Competition

Mythri Ambatipudi Advances to San Diego to Compete against Top Students from across the Nation and Canada SOUTH SAN FRANCISCO (Apr 21, 2017) –​ California Life Sciences Institute (CLSI) today named Saint Francis High School, Grade 11, Mythri Ambatipudi of Mountain View as the winner of the 2017 Amgen Bay Area BioGENEius Challenge, the premier competition … Continue reading California Life Sciences Institute Names 2017 Winner of Amgen Bay Area BioGENEius Competition

Small Start-Ups Can Claim up to $250,000 in Research Credit Against Payroll Tax Liability

SOUTH SAN FRANCISCO (Apr 3, 2017) –​ The Internal Revenue Service last Thursday (Mar. 30) issued interim guidance explaining how eligible small businesses can take advantage of a new option enabling them to apply part or all of their research credit against their payroll tax liability, instead of their income tax liability. Before 2016, taxpayers could … Continue reading Small Start-Ups Can Claim up to $250,000 in Research Credit Against Payroll Tax Liability

CARB-X Injects Up to $48 Million to Accelerate First Powered By CARB-X Portfolio of Drug Discovery and Development Projects to Tackle Antibiotic Resistance

3 POTENTIAL NEW CLASSES OF ANTIBIOTICS, 4 INNOVATIVE NON-TRADITIONAL PRODUCTS AND 7 NEW MOLECULAR TARGETS AGAINST THE MOST URGENT DEADLIEST ‘SUPERBUGS’ (WASHINGTON, D.C./ LONDON, U.K.) – The Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, or CARB-X (www.carb-x.org), announced today it is investing US$24 million immediately and up to $24 million in milestone-based additional payments over three … Continue reading CARB-X Injects Up to $48 Million to Accelerate First Powered By CARB-X Portfolio of Drug Discovery and Development Projects to Tackle Antibiotic Resistance

CSU I-Corps Partners to Offer Bio-entrepreneurship Workshop to Researchers Nationwide

SOUTH SAN FRANCISCO (Feb. 13, 2017) –​The National Science Foundation (NSF) announced eight new Inclusive Entrepreneurship supplemental awards under the Innovation Corps (I-CorpsTM) program, including one to CSU I-Corps, a member of the National Innovation Network. The Inclusive Entrepreneurship grants are designed to “increase participation and promote inclusion of underrepresented populations in the National Innovation … Continue reading CSU I-Corps Partners to Offer Bio-entrepreneurship Workshop to Researchers Nationwide

Statement issued by CLSI President & CEO Lori Lindburg to ensure legitimate travel by immigrants and refugees from all countries to the US

SOUTH SAN FRANCISCO (Jan. 31, 2017) – The vibrancy of California’s life sciences sector depends heavily upon providing employers and research institutions with a talent pool that is second to none. The California life sciences industry attracts the best and brightest scientists, students, faculty and other experts from around the globe. These individuals must comply … Continue reading Statement issued by CLSI President & CEO Lori Lindburg to ensure legitimate travel by immigrants and refugees from all countries to the US

CLSI’s FAST Life Science Accelerator Announces Statewide Expansion

CLSI announced today that it will celebrate the expansion of its FAST Accelerator program to Davis and Southern California – and its designation as the West Coast accelerator for combating antimicrobial resistance (CLSI CARB-X) – at a special FAST Showcase & Reception on Dec. 13 at the Wilsey Theater and Education Studio of the War Memorial Building in San Francisco.

2017 California Life Sciences Industry Report Shows Increased Employment, Growth And Robust Treatment Pipeline

California Life Sciences Association (CLSA) and PwC US issue new report indicating that California’s life sciences industry has 1,269 new medicines in the development pipeline, and in 2015, employed more than 287,000 people, brought in $148 billion in total revenue, paid over $116,000 in average wages, attracted $4.4 billion in venture capital investment and more.